1276 related articles for article (PubMed ID: 19249123)
1. Immunomodulatory effects of curcumin treatment on murine schistosomiasis mansoni.
Allam G
Immunobiology; 2009; 214(8):712-27. PubMed ID: 19249123
[TBL] [Abstract][Full Text] [Related]
2. Vasoactive intestinal peptide inhibits liver pathology in acute murine schistosomiasis mansoni and modulates IL-10, IL-12 and TNF-alpha production.
Allam G
Immunobiology; 2007; 212(8):603-12. PubMed ID: 17869638
[TBL] [Abstract][Full Text] [Related]
3. Human schistosomiasis mansoni: immune responses during acute and chronic phases of the infection.
Caldas IR; Campi-Azevedo AC; Oliveira LF; Silveira AM; Oliveira RC; Gazzinelli G
Acta Trop; 2008; 108(2-3):109-17. PubMed ID: 18577364
[TBL] [Abstract][Full Text] [Related]
4. Immunization with SmIg, a novel tegument protein from Schistosoma mansoni, fails to induce protection in mice but reduces liver pathology.
Pinho JM; Cardoso FC; Lopes DO; Pinheiro CS; Caliari MV; Oliveira FM; Leite LC; Oliveira SC
Parasitology; 2010 Jun; 137(7):1079-88. PubMed ID: 19835649
[TBL] [Abstract][Full Text] [Related]
5. Lack of antigen-specific Th1 response alters granuloma formation and composition in Schistosoma mansoni-infected MyD88-/- mice.
Layland LE; Wagner H; da Costa CU
Eur J Immunol; 2005 Nov; 35(11):3248-57. PubMed ID: 16276483
[TBL] [Abstract][Full Text] [Related]
6. Intranasal administration of a Schistosoma mansoni glutathione S-transferase-cholera toxoid conjugate vaccine evokes antiparasitic and antipathological immunity in mice.
Sun JB; Mielcarek N; Lakew M; Grzych JM; Capron A; Holmgren J; Czerkinsky C
J Immunol; 1999 Jul; 163(2):1045-52. PubMed ID: 10395703
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor plays a role in Schistosoma mansoni egg-induced granulomatous inflammation.
Joseph AL; Boros DL
J Immunol; 1993 Nov; 151(10):5461-71. PubMed ID: 8228238
[TBL] [Abstract][Full Text] [Related]
8. Tolerization of mice to Schistosoma mansoni egg antigens causes elevated type 1 and diminished type 2 cytokine responses and increased mortality in acute infection.
Fallon PG; Dunne DW
J Immunol; 1999 Apr; 162(7):4122-32. PubMed ID: 10201937
[TBL] [Abstract][Full Text] [Related]
9. Congenital exposure to Schistosoma mansoni infection: impact on the future immune response and the disease outcome.
Othman AA; Shoheib ZS; Saied EM; Soliman RH
Immunobiology; 2010; 215(2):101-12. PubMed ID: 19457572
[TBL] [Abstract][Full Text] [Related]
10. Kupffer cells from Schistosoma mansoni-infected mice participate in the prompt type 2 differentiation of hepatic T cells in response to worm antigens.
Hayashi N; Matsui K; Tsutsui H; Osada Y; Mohamed RT; Nakano H; Kashiwamura S; Hyodo Y; Takeda K; Akira S; Hada T; Higashino K; Kojima S; Nakanishi K
J Immunol; 1999 Dec; 163(12):6702-11. PubMed ID: 10586067
[TBL] [Abstract][Full Text] [Related]
11. Impact of interleukin-1 and interleukin-6 in murine primary schistosomiasis.
El Ridi R; Wagih A; Salem R; Mahana N; El Demellawy M; Tallima H
Int Immunopharmacol; 2006 Jul; 6(7):1100-8. PubMed ID: 16714213
[TBL] [Abstract][Full Text] [Related]
12. Antibody responses to the fucosylated LacdiNAc glycan antigen in Schistosoma mansoni-infected mice and expression of the glycan among schistosomes.
Nyame AK; Leppänen AM; Bogitsh BJ; Cummings RD
Exp Parasitol; 2000 Dec; 96(4):202-12. PubMed ID: 11162373
[TBL] [Abstract][Full Text] [Related]
13. Mice with a targeted deletion of the IgE gene have increased worm burdens and reduced granulomatous inflammation following primary infection with Schistosoma mansoni.
King CL; Xianli J; Malhotra I; Liu S; Mahmoud AA; Oettgen HC
J Immunol; 1997 Jan; 158(1):294-300. PubMed ID: 8977202
[TBL] [Abstract][Full Text] [Related]
14. Immunization with rP22 induces protective immunity against Schistosoma mansoni: effects on granuloma down-modulation and cytokine production.
Rezende CM; Silva MR; Santos IG; Silva GA; Gomes DA; Goes AM
Immunol Lett; 2011 Dec; 141(1):123-33. PubMed ID: 21945176
[TBL] [Abstract][Full Text] [Related]
15. The Schistosoma bovis Sb14-3-3zeta recombinant protein cross-protects against Schistosoma mansoni in BALB/c mice.
Siles-Lucas M; Uribe N; López-Abán J; Vicente B; Orfao A; Nogal-Ruiz JJ; Feliciano AS; Muro A
Vaccine; 2007 Oct; 25(41):7217-23. PubMed ID: 17707955
[TBL] [Abstract][Full Text] [Related]
16. Correlation between infection intensity, serum immunoglobulin profile, cellular immunity and the efficacy of treatment with praziquantel in murine schistosomiasis mansoni.
Nessim NG; Demerdash Z
Arzneimittelforschung; 2000 Feb; 50(2):173-7. PubMed ID: 10719623
[TBL] [Abstract][Full Text] [Related]
17. Antischistosomal and liver protective effects of Curcuma longa extract in Schistosoma mansoni infected mice.
El-Ansary AK; Ahmed SA; Aly SA
Indian J Exp Biol; 2007 Sep; 45(9):791-801. PubMed ID: 17907745
[TBL] [Abstract][Full Text] [Related]
18. Effects of pentoxifylline during Schistosoma mansoni infection in Swiss mice: an analysis of worm burden, fecundity and liver histopathology.
Mati VL; Freitas RM; Melo AL
J Helminthol; 2010 Dec; 84(4):348-54. PubMed ID: 20109246
[TBL] [Abstract][Full Text] [Related]
19. Schistosomal granuloma modulation. I. Schistosoma mansoni worm antigens CAA and CCA prime egg-antigen-induced hepatic granuloma formation.
Jacobs W; van Dam G; Bogers J; Deelder A; Van Marck E
Parasitol Res; 1999 Jan; 85(1):7-13. PubMed ID: 9950221
[TBL] [Abstract][Full Text] [Related]
20. Excretory-secretory product of fasciola hepatica worm protects against Schistosoma mansoni infection in mice.
Hamed MA
Indian J Exp Biol; 2006 Jul; 44(7):554-61. PubMed ID: 16872044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
